FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

ULTRAGENYX PHARMACEUTICAL INC.: capex

One fact, its scope and the complete path back to the official record.

Period: 2019-01-01 – 2019-09-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/ae5f0bb3-de72-42c7-8732-65d505e31295

Reported value

$13.332M{"amount": 13332000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
ULTRAGENYX PHARMACEUTICAL INC.
Metric
capex
Period
2019-01-01 – 2019-09-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001564590-19-040541 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:13:48.701378+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001515673/capex/2019-09-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.